Financials

News Ideas Discussions Technicals Seasonals

VRAX fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to Virax Biolabs Group Limited operating, investing, and financing activities

VRAX free cash flow for H2 24 is -2.81 M USD. For 2024, VRAX free cash flow was -5.2 M USD and operating cash flow was -4.6 M USD.

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: USD

TTM

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—